Net Cash Settlement Amount = Cash Settlement Amount - Exercise Expense Charged by Issuer By; In case of Call Warrant and Underlying Asset is Stock :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Exercise Ratio In case of Put Warrant and Underlying Asset is Stock :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Exercise Ratio In case of Call Warrant and Underlying Asset is Index :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Multiplier In case of Put Warrant and Underlying Asset is Index :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Multiplier In case of Call Warrant and Underlying Asset is Foreign Stock :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Exercise Ratio X Exchange rate In case of Put Warrant and Underlying Asset is Foreign Stock :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Exercise Ratio X Exchange rate In case of Call Warrant and Underlying Asset is Foreign Index :
Cash Settlement Amount = (Settlement Price - Exercise Price) X Multiplier X Exchange rate In case of Put Warrant and Underlying Asset is Foreign Index :
Cash Settlement Amount = (Exercise Price - Settlement Price) X Multiplier X Exchange rate
Any Derivative Warrant (DW) will automatically be exercised if the Net Cash Settlement Amount on the Automatic Exercise Date is greater than zero (without notice being given to the Holders). The Issuer will pay to the Holders the Net Cash Settlement Amount (if any) with procedure defined in Terms and Condition.
The Holders can deny the exercise of DW by informing their broker in accordance with procedures stipulated by their broker.
Signature ________________________________
(Mr.Nattapat Tanawilai)
Assistant Manager
Authorized Persons to Disclose Information
This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and
completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Bumrungrad Hospital pcl published this content on 27 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 July 2022 10:43:05 UTC.
Bumrungrad Hospital Public Company Limited is a healthcare provider in Thailand and Southeast Asia, providing holistic and healthcare services for both outpatients and inpatients. The Company operates through a hospital and health care center business. It operates a private hospital business in Bangkok with 580 licensed beds and a capacity for over 5,500 outpatients per day. Its Telemedicine service provides consultation through information technology to support remote access consultation. Its preventive genomics and family check-up services provide diagnosis, treatment, and advice, including risk assessment and screening for diseases caused by genetic abnormalities. Its Bumrungrad@Home service provides health care services for patients and families at their homes as necessary. Its Breast Center delivers holistic medical services regarding breast health for all genders. Its sports medicine and joint center offer an integrated approach to treating musculoskeletal problems.